Literature DB >> 7702637

Vesamicol analogues as sigma ligands. Molecular determinants of selectivity at the vesamicol receptor.

S M Efange1, R H Mach, C R Smith, A B Khare, C Foulon, S K Akella, S R Childers, S M Parsons.   

Abstract

The present study compares the affinities of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, 1) and selected analogues of the latter at the vesamicol receptor (VR) with the corresponding affinities at sigma 1 and sigma 2 binding sites. For this study, the parent structure 1 was divided into three fragments: A (cyclohexyl), B (piperidyl) and C (phenyl). Vesamicol analogues were then selected to reflect structural modifications in these fragments. Consistent with earlier reports, vesamicol was found to exhibit nanomolar affinities at the VR and sigma 1 and sigma 2 sites, resulting in poor selectivity for the VR over the sigma sites. Vesamicol analogues characterized by an acyclic A-fragment showed moderate to low affinities at the VR and moderate to high affinities at sigma 1 and sigma 2 sites. As a result, many of these analogues showed poor selectivity for the VR. Replacement of the C4 carbon of 1 with a halobenzyl amine resulted in higher affinities at the VR coupled with moderate to low affinities at sigma 1 and sigma 2 sites. The introduction of a benzofused substituent at the C4 and C5 positions of 1 (compound 2) resulted in a 200-fold increase in affinity at the VR accompanied by a 5- to 6-fold decrease in affinity at sigma 1 and sigma 2 sites relative to the parent structure. Consequently, compound 2 showed 12,000-fold higher affinity at the VR than at sigma sites. Restricting the rotation of fragment C relative to B (by means of alkyl and alkenyl bridges) generally yielded analogues with subnanomolar affinities at the VR. The corresponding affinities of these spirofused conformationally restricted analogues were moderate to poor at sigma 1 and sigma 2 sites when fragment A was preserved. In contrast, the affinities at sigma 1 and sigma 2 sites were decreased 3- to 11-fold when fragment A was modified at position C4 and decreased up to 100-fold with benzofusion at the C4 and C5 positions of fragment A. Consequently, the spirofused analogues 15-19 were among the most selective VR ligands examined. Thus, the effect of conformational restriction in fragments A and B-C is to increase affinity at the VR while decreasing affinity at sigma 1 and sigma 2 sites, and thereby increasing selectivity for the VR over the sigma sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702637     DOI: 10.1016/0006-2952(94)00541-s

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate.

Authors:  Xuyi Yue; Hongjun Jin; Hui Liu; Zonghua Luo; Xiang Zhang; Kota Kaneshige; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  Org Biomol Chem       Date:  2017-06-21       Impact factor: 3.876

2.  Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors.

Authors:  Wei Wang; Jinquan Cui; Xiaoxia Lu; Prashanth K Padakanti; Jinbin Xu; Stanley M Parsons; Robert R Luedtke; Nigam P Rath; Zhude Tu
Journal:  J Med Chem       Date:  2011-07-20       Impact factor: 7.446

3.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter.

Authors:  Simon M N Efange; Anil B Khare; Krystyna von Hohenberg; Robert H Mach; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Hongjun Jin; Jinquan Cui; Ruike Wang; Junfeng Li; Hubert P Flores; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

6.  Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.

Authors:  Zhude Tu; Xiang Zhang; Hongjun Jin; Xuyi Yue; Prashanth K Padakanti; Lihai Yu; Hui Liu; Hubert P Flores; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter
Journal:  Bioorg Med Chem       Date:  2015-06-05       Impact factor: 3.641

7.  Regulation of vesicular acetylcholine transporter by the activation of excitatory amino acid receptors in the avian retina.

Authors:  Nelson Enrique Loureiro-dos-Santos; Marco Antonio M Prado; Ricardo Augusto de Melo Reis; Patrícia F Gardino; Maria Christina F de Mello; Fernando G de Mello
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

8.  Functional and neurobiological similarities of aging in monkeys and humans.

Authors:  M L Voytko
Journal:  Age (Omaha)       Date:  1997-01

9.  Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter.

Authors:  Zhude Tu; Simon M N Efange; Jinbin Xu; Shihong Li; Lynne A Jones; Stanley M Parsons; Robert H Mach
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

10.  Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.

Authors:  Parul Khare; Aubrey R White; Stanley M Parsons
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.